Clinical Research Participant | Biodecision, Inc. August 1994 | Highland Park, Pittsburgh, PA
Bioequivalence Protocol Compliance: Successfully completed a residential pharmaceutical study for Biodecision, Inc., a firm specializing in testing excellence for new and generic medications. Maintained 100% adherence to high-frequency vitals monitoring and metabolic data collection protocols.
Environmental Resilience & Baseline Stability: Navigated a high-stakes residential environment (24/7 onsite monitoring) by maintaining extreme personal discipline. Served as a critical “baseline” subject, requiring constant physiological stability and “zero-deviation” protocol adherence. This experience established an early foundation in systematic reliability and the importance of deterministic outcomes in complex testing environments.
The “Strategic Asset” Reflection
The Ghost in the Machine: In 1994, I was living in a Victorian house in Highland Park, attending the Art Institute, and trying to navigate a world that felt increasingly volatile. When my job at Revco became untenable due to a roommate conflict, I pivoted to clinical research. I answered an ad for Biodecision, Inc. at 5900 Penn Avenue. They were looking for “Healthy Males” to test the equivalence of drugs. In technical terms, I was the Reference Environment.
It was a loud, bunk-bed environment where the “people in white” checked your vitals at all hours of the night. I was “ghost-white” pale back then—so much so that the doctors constantly worried I was crashing. I wasn’t; I was just the guy who stayed indoors, did puzzles, and followed the rules.
I watched people get kicked out every weekend because they couldn’t stay “clean” or stick to the protocol. For me, it was a lesson in System Uptime. In tech, it’s easy to get distracted by a project’s “loudness” or the discomfort of a deadline. But my time “selling my body for science” taught me that if you can stay hydrated, follow the spec, and keep your internal logic sound, you can survive any environment and reach the final check.
This shaped my approach to software: The environment is the foundation of the test. Whether I’m testing a generic blood pressure pill or a new React component, the goal is the same: eliminate variables until only the performance remains. I reached the “final check” at Biodecision because I knew how to be a constant in a room full of variables.
